A single centre, double-blind, placebo-controlled study to evaluate the effect of the consumption of Bacillus coagulans at a daily dose of 1 x 10⁹ CFU on bowel habits, intestinal microbiota and gastrointestinal symptoms in healthy adults.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Stool frequency
Timeframe: 6 weeks period, from enrollment to the end of the study.
Stool consistency.
Timeframe: 6 weeks period, from enrollment to the end of the study.
Improvement of constipation rate
Timeframe: 6 weeks period, from enrollment to the end of the study.
Improvement in the defection effort
Timeframe: 6 weeks period, from enrollment to the end of the study.
Changes in intestinal microbiota
Timeframe: 4 weeks period, assessment at Day 0, Day 14 and Day28
Improvement in digestive symptoms scores
Timeframe: 6 weeks; assessment at Day 0, Day 14 and Day 28
Improvement in upper GI symptoms
Timeframe: 6 weeks; assessment at Day 0, Day 14 and Day 28